Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article
Comparing the Prevalence and Drug Treatment Rates of Diabetes, Hypertension and Dyslipidemia between Japan and Brazil, using 2013 National Health Surveys
Angelo Jose Goncalves Bos1*, Luisa Braga Jorge1, Joel Hirtz do Nascimento Navarro1, Leticia Farias Gerlack2, Josemara de Paula Rocha1, Gabriela Guimaraes Oliveira1, Jessika Cefrin1, Vanessa Cuentro1, Claudine Lamanna Schirmer1 and Maria Marina Serrao Cabral11Institute of Geriatrics and Gerontology, Pontifical Catholic University of Rio Grande do Sul, Brazil
2National University of Brazilia, Brazil
- Corresponding Author:
- Angelo Jose Goncalves Bos
Institute of Geriatrics and Gerontology, Pontifical
Catholic University of Rio Grande do Sul, Brazil
Tel: + 555133536229
E-mail: angelo.bos@pucrs.br
Received Date: September 29, 2015 Accepted Date: December 04, 2015 Published Date: December 11, 2015
Citation: Bos AJG, Jorge LB, Navarro JHN, Gerlack LF, Rocha JP, et al. (2015) Comparing the Prevalence and Drug Treatment Rates of Diabetes, Hypertension and Dyslipidemia between Japan and Brazil, using 2013 National Health Surveys. J Clin Diabetes Pract 1:103. doi:10.4172/jcdp.1000103
Copyright: © 2015 Bos AJG et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Diabetes and other Non-Communicable Diseases (NCD) are public health concerns in both developed and developing countries. Brazil and Japan have made publically available National Health Surveys focus also in the prevalence of NCD, among them Diabetes, Hypertension and Dyslipidemia. This study offers a unique opportunity to understand the prevalence of NCD in economically different countries exploring also the drug use for those conditions. The results showed that the Japanese population has higher prevalence of all conditions, but Brazil presented a quite substantial number of participants who never checked for those conditions, mainly for dyslipidemia. Japanese survey did not check for that information. Treatment rate was higher in the Brazilian population but the specific mortality rate for both Diabetes and Hypertension was also higher in this country. We concluded that NCD are frequent health problems in both countries. Brazil has improved the access to medication to NCD conditions, although it still has a much higher mortality rate. The treatment of NCD is not only performed through drug treatment but also by public health education which seems to be more effective performed in the Japanese population.
